Goldman Sachs’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Goldman Sachs’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$466K	Buy	+8,904	New	+$453K	﹤0.01%	5643
2017 Q2	–	Sell	-50,036	Closed	-$1.29M	–	6944
2017 Q1	$1.29M	Hold	50,036	–	–	﹤0.01%	4160
2016 Q4	$1.15M	Hold	50,036	–	–	﹤0.01%	4329
2016 Q3	$1.31M	Sell	50,036 -379	-0.8%	-$9.46K	﹤0.01%	4172
2016 Q2	$1.14M	Buy	+50,415	New	+$1.2M	﹤0.01%	4081

Other funds holding SBIO

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIS

Connors Investor Services Wyomissing, Pennsylvania $1.08B AUM 31.31% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

MWM

Moran Wealth Management Naples, Florida $3.27B AUM 25.8% 1-Year Est. Return

Goldman Sachs's SBIO Position: Q1 2026 in Review

Goldman Sachs opened a new position in ALPS Medical Breakthroughs ETF (SBIO) in Q1 2026: 8,904 shares worth $466K. The stake represents ﹤0.01% of the portfolio and ranks #5643 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in SBIO as recently as Q1 2017.

Goldman Sachs first reported a position in SBIO in Q2 2016 and has held it in 5 quarters since. The position peaked at $1.31M in Q3 2016. 59 funds tracked by Wall St. Rank hold SBIO as of Q1 2026.

Goldman Sachs held 8,904 shares of ALPS Medical Breakthroughs ETF worth $466K as of Q1 2026.
ALPS Medical Breakthroughs ETF was a new Goldman Sachs position in Q1 2026.
ALPS Medical Breakthroughs ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5643 holding.
Goldman Sachs first reported a position in ALPS Medical Breakthroughs ETF in Q2 2016 and has held it in 5 quarters since.
Goldman Sachs's ALPS Medical Breakthroughs ETF position peaked at $1.31M in Q3 2016.
59 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.